Pharma Marketing Network

This article, written by health communications veteran, Harry Sweeney, is a frank assessment of the pharmaceutical industy's plodding approach to e-communication and e-marketing based on a review of a recent industry conference.

Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it.

Two of the biggest, if not THE biggest, US-based pharmaceutical companies -- Pfizer and Merck --have made separate announcements in preparation for Wall Street...

Results of the WSJ Online/Harris Interactive Health-care Poll regarding off-label use of drugs were recently published ("Adults Are Divided On Off-Label Use Of Prescription...

Rich Meyer, author the World of DTC Marketing blog, drew my attention to a recent Wall Street Journal article entitled "Am I Dreaming, or...

Pharma Marketing Roundtable experts and call-in guests discuss what changes the pharmaceutical might expect from the Democratic 110th Congress.

A $190,000 Levitra "ad" campaign in Hong Kong--developed by Interpublic Group public-relations agency Golin Harris--increased sales of Levitra in Hong Kong by 244% from...

Chantix, Pfizer's new smoking-cessation drug, requires a different kind of marketing program, according to a recent article in the Wall Street Journal ("Marketing New...

EyeOnFDA reports (see "Hold It!"):"Senator Charles Grassley (R-Iowa) has gone and put a hold on the nomination of Dr. Andrew C. von Eschenbach. There...

It's official -- well, all except for the rubber stamp from HHS and Congressional approval -- the drug industry has agreed to pay the...